Global Brain Monitoring Market to Reach $9.94 Billion in 2028

The “Brain Monitoring Market By Product Type, By End Use, By Application, and By Region” report has been added to ResearchAndMarkets.com’s offering.

The global brain monitoring market size is expected to reach USD 9,942.6 Million in 2028 and register a revenue CAGR of 5.9% over the forecast period, according to the latest report. The rising number of brain disorders, favorable government regulations regarding the adoption of brain monitoring devices, and technological advancements are some of the notable factors projected to fuel market growth over the forecast period.

In recent years, there has been a significant rise in the prevalence of brain disorders worldwide. According to the National Institute of Mental Health (NIMH), in the United States, approximately one in every five adults suffers from a mental illness. The global prevalence of Alzheimer’s disease is projected to reach 131.5 million by 2050. Moreover, the increasing geriatric population and the rising awareness about brain disorders are other major factors that are expected to drive market growth over the forecast period.

The favorable government regulations regarding the adoption of brain monitoring devices are expected to propel market growth over the forecast period. For instance, in February 2019, the U.S. Food and Drug Administration (FDA) cleared the RNS System for treating epilepsy.

The system is a brain-responsive neurostimulation device that helps in reducing seizure frequency by delivering targeted electrical stimulations to specific areas of the brain that are associated with seizure onset. Similarly, in January 2019, the FDA cleared the Intellis platform for treating chronic pain. The system is a spinal cord stimulator that helps in reducing pain by delivering electrical stimulations to specific areas of the spinal cord.

The increasing adoption of brain monitoring devices is expected to fuel market growth over the forecast period. For instance, in September 2019, researchers at the University of Glasgow developed a brain-computer interface (BCI) system that can be used to type at eight words per minute.

The system uses a non-invasive electroencephalography (EEG) headset to record brain activity and translate it into text. Similarly, in August 2019, a team of researchers at the University of Minnesota developed a non-invasive brain-computer interface (BCI) system that can be used to control robotic limbs. The system uses alternating current stimulation (ACS) to modulate the activity of neurons and generate signals that can be decoded by a computer to control robotic limbs.

Product Type Outlook (Revenue, USD Million; 2018-2028)

  • Electroencephalography (EEG) Devices
  • Magnetoencephalography (MEG) Devices
  • Transcranial Doppler (TCD) Devices
  • Intracranial Pressure (ICP) Monitors
  • Cerebral Oximeters
  • Magnetic Resonance Imaging (MRI) Devices
  • Computerized Tomography (CT) Devices
  • Positron Emission Tomography (PET) Devices
  • Electromyography Devices
  • Sleep Monitoring Devices

End Use Outlook (Revenue, USD Million; 2018-2028)

  • Hospitals
  • Neurology Centers
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Application Outlook (Revenue, USD Million; 2018-2028)

  • Parkinson’s Disease
  • Traumatic Brain Injury
  • Epilepsy
  • Dementia
  • Huntington’s Disease
  • Sleep Disorders
  • Stroke
  • Headache Disorders

Regional Outlook (Revenue, USD Million; 2018-2028)

Market Dynamics

Market drivers

  • Growing incidences of neurological disorders
  • Increasing prevalence of traumatic brain injuries
  • Technological Advancement in brain monitoring devices

Market restraints analysis

  • High cost of brain monitoring procedure and devices
  • Strict government rules for approval of devices

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

Chapter 4. Brain Monitoring Market Segmentation & Impact Analysis

Chapter 5. Brain Monitoring Market By Product Type Insights & Trends

Chapter 6. Brain Monitoring Market By End Use Insights & Trends

Chapter 7. Brain Monitoring Market Application Insights & Trends

Chapter 8. Brain Monitoring Market Regional Outlook

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

 Companies Mentioned

  • Advanced Brain Monitoring Inc.
  • CAS Medical Systems Inc.
  • Compumedics Ltd.
  • Electrical Geodesics Inc.
  • General Electric Company (GE Healthcare)
  • Koninklijke Philips N.V. (Philips Healthcare)
  • Medtronic PLC.
  • Natus Medical Incorporated
  • Neural Analytics Inc
  • Nihon Kohden Corporation
  • Siemens Healthineers AG

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”